Abstract Details

Title Can we stop immunomodulatory treatment in secondary progressive MS?

Topic Multiple Sclerosis

Presentation(s) (-)

Poster/Presentation
Number 002

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Julien Bonenfant PRESENTER	No disclosure on file
	No disclosure on file
Emmanuelle Le Page (CHR Pontchaillou)	Emmanuelle Le Page has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for MERCK. Emmanuelle Le Page has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Gilles Edan, MD	No disclosure on file
	No disclosure on file
	No disclosure on file

��ɫ����